Research Assistant

Project Background

• Malaria remains one of the leading causes of morbidity and mortality among children in Nigeria, accounting for a significant proportion of global malaria cases and deaths.
• While national statistics provide aggregated estimates, there is limited disaggregated data describing how severe malaria burden, clinical manifestations, and outcomes vary across age groups. Recognizing this evidence gap, the DISBURMA Study (Disaggregating the Burden of Severe Malaria in Paediatric Populations in Nigeria) aims to provide comprehensive, age-specific insights into severe malaria morbidity and mortality patterns among children and adolescents up to 20 years of age.
• The findings will guide health system planning, case management protocols, and malaria control strategies. The study’s overarching aim is to quantify the burden, clinical characteristics, and outcomes of severe malaria among paediatric and adolescent populations (0–20 years).

Purpose of the assignment
This is a multi-centre retrospective cohort study using routine hospital records of paediatric and adolescent admissions with severe malaria from January 1, 2021, to December 31, 2025. Study sites will include the 18 health facilities selected to represent Nigeria's epidemiological zones, urban/rural mix, and population density. The specific objectives include to:

• Estimate age-specific incidence, clinical presentations, and case-fatality rates of severe malaria among children and adolescents aged 0–20 years across multiple facilities in Nigeria (2021–2025).
• Examine temporal trends in severe malaria admissions and deaths by age, sex, SMC and non-SMC zones.
• Identify key comorbidities and complications associated with severe malaria.
• Assess facility-level differences in severe malaria burden and management practices.

Scope of work

• The DISBURMA Study will adopt a retrospective, multi-centre hospital-based cohort design, using data from 18 selected health facilities across Nigeria’s six geopolitical zones.
• These facilities represent diverse malaria epidemiological profiles, urban-rural contexts, and population densities. The retrospective analysis will cover hospital admission records from January 2021 to December 2025, focusing on children and adolescents diagnosed with severe malaria.
• All admissions of patients aged 0–20 years with clinically or laboratory-confirmed severe malaria will be eligible for inclusion. Data abstraction will use a standardized electronic data capture (EDC) system (SurveyCTO), guided by a detailed extraction form and variable dictionary. Key variables will include demographic information, clinical presentation, laboratory findings, treatment details, comorbidities, and patient outcomes.
• A minimum of 100 severe malaria cases among 0-20 years over 5 years (2021-2025) will be extracted from hospital records.

Level of Effort (LOE):

• Data extraction of severe malaria cases from inpatient medical records (case notes), laboratory registers (malaria microscopy/RDT results), paediatric and emergency department logs, referral and discharge forms and national severe malaria register between 2021-2025.
• The research coordinator will provide technical oversight on the daily data extraction of severe malaria cases and the research assistants.

Specific Tasks

• Receive briefing from Malaria and Public Health team on the assignment
• Identify from registers and case notes the severe malaria cases
• Work with the medical record officers to ensure that the records are retrieved, extracted and send to the electronic database using the data collection tool.
• Capture data elements available in all primary data sources, which could include:
  • Unique record ID (study-specific)
  • Facility identifier
  • Patient demographics: age (in months/years), sex, residence (urban/rural)
  • Date of admission, date of discharge/death
  • Diagnosis of Severe malaria: Clinical Diagnosis or Laboratory diagnosis of Severe Malaria
  • Pre referral Treatment (Tick as appropriate): Rectal Artesunate vs. other Antimalarial
  • Parenteral Treatment (Tick as appropriate): Inj. Artesunate, Inj. Artemether, Inj. Quinine and other antimalarials (specify)
• Oral follow up to Parenteral treatment (Tick as appropriate): Oral ACTs, Oral Quinine and other forms of Oral Antimalarials
• Outcome of treatment (Tick as appropriate): Improved & Discharged, Death, Absconded / Discharged Against Medical Advice (DAMA) and Referred for further treatment
• Clinical presentation: signs/symptoms (coma, impaired consciousness, prostration, severe anemia, respiratory distress, hypoglycaemia, repeated convulsions, jaundice, renal impairment, shock), vital signs at admission
• Laboratory results: malaria test type and result, haemoglobin/PCV, blood glucose, parasite density (if available)
• Treatment variables: antimalarial therapy (parenteral artesunate, quinine), blood transfusion, antibiotics, anticonvulsants, supportive care (oxygen), time to first dose
• Co-morbidities and complications: HIV status (if documented), sickle cell disease, severe malnutrition, pneumonia, sepsis
• Referral source and time from symptom onset to admission

• Respond to related queries and data needs and requests from the project’s technical team and key national and sub-national partners, NMEP and SMEP.

Deliverables

• List of identified severe malaria cases in the assigned health facility
• Data extracted from all primary data sources
• Data submitted from all records.

Expert Profile

• The research assistants will have a minimum of diploma in a health-related course with experience in health services provision.

Qualifications , experience and skills
Essential:

• Currently working in the pediatric or medical ward of the project hospital as a staff or volunteer
• Registered nurse/midwife, hold diploma or degree in health-related sciences, or equivalent subject-matter experience
• Significant experience in inpatient care
• Experience in the use of electronic platform to capture and report data
• Familiarity with secondary, tertiary and private hospitals
• Excellent communication skills.

Desirable:

• Experience of collaborating with government institutions and non-governmental organisations or academic institutions
• Have understanding of diverse audiences and culture
• Have obtained training in health research ethics.

Candidates Resident in this LGA are strongly encouraged to apply:​​​​​​​

Application Closing Date
24th September, 2026; before 5:00PM.

How to Apply
Interested and qualified candidates should

Note

• Interested and qualified candidates who are passionate and willing to contribute towards the achievement of our goals 
• Safeguarding Requirement:
• Candidates must complete the Malaria Consortium Safeguarding Course on Kaya using this link Log in to the site | Kaya as you will be mandated to submit the certificate at the point engagement. Only candidates who provide a valid certificate will proceed with the engagement process.
• Kindly note that applicants who do not follow this specification will be disqualified and only Shortlisted candidates will be contacted.
• Applications will be reviewed on a rolling basis, and as a result, the process may conclude before the advertised deadline. Therefore, early applications are highly encouraged.
• NB: Malaria Consortium does not accept or ask for payment during recruitment. We also would not accept hardcopy CVs; all applications should be sent through the above link.
• Safeguarding: Malaria Consortium is committed to protecting children and vulnerable adults and ensuring that all staff, partners, and representatives uphold the highest standards of ethical conduct. Our Safeguarding Policy outlines our responsibility to prevent abuse, harassment, and exploitation in all areas of our work. We expect everyone working with us staff, consultants, volunteers, and partners to adhere to this policy and our Code of Conduct. By following these standards, we help create safe environments and reduce any risk of harm in the communities we serve.

Share this job: